Mission Cure Pharma Private Limited
About Mission Cure Pharma Private Limited
Data last updated:
Mission Cure Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24233GJ2013PTC077247. Its GSTIN is 24AAICM8947R1ZH (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Devangkumar Jashvantlal Shah and Udayan Jashwantlal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.84 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹48.64 Lakh (net margin 17.1%) and EBITDA of ₹67.15 Lakh (EBITDA margin 23.6%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mission Cure Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressGround Floor Shop – 9 Binali Complex Opp. Torrent Power Ltd. Sola Road Nara, Npura, Ahmedabad, Gujarat, India – 380013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mission Cure Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mission Cure Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mission Cure Pharma Private Limited, buy the company report.
Financials of Mission Cure Pharma Private Limited
FY 2025 filings availableMission Cure Pharma Private Limited reported revenue of ₹2.84 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 2% fall in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.6% | ||||
| Net Profit Margin | 17.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mission Cure Pharma Private Limited, buy the company report.
Board of directors of Mission Cure Pharma Private Limited
Mission Cure Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devangkumar Jashvantlal Shah Also directs: DJS Property Solution Private Limited | Director | 17 Oct 2013 | 13 Years 0 Months | Current |
| Udayan Jashwantlal Shah | Director | 09 Jun 2017 | 9 Years 5 Months | Current |
Peer comparison
Mission Cure Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Roots Life Sciences (India) Private Limited | ₹2.85 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Convene Pharma Private Limited | ₹2.85 Cr (FY 2024) | 87.0% | Shimla, Himachal Pradesh, India | |||
| Tradeniger Impex Private Limited | ₹2.84 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| Infochem Pharma Private Limited | ₹2.84 Cr (FY 2024) | 39.0% | Kankerbagh, Bihar, India | |||
| Mission Cure Pharma Private Limitedthis company | ₹2.84 Cr (FY 2025) | ₹48.64 Lakh | 17.1% | -2.0% | Ahmedabad, Gujarat, India | |
| Glosun Pharmaceuticals Private Limited | ₹2.84 Cr (FY 2025) | 22.0% | Cuttack, Odisha, India | |||
| Popular Distributors Private Limited | ₹2.83 Cr (FY 2024) | -13.0% | Ratnagiri, Maharashtra, India | |||
| Genetech Biotech Private Limited. | ₹2.83 Cr (FY 2025) | -29.0% | Delhi, India |
To see the full peer comparison of Mission Cure Pharma Private Limited, buy the company report.
Auditor
Mission Cure Pharma Private Limited is audited by BORKAR & MUZUMDAR for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BORKAR & MUZUMDAR | FY 2021 | 101569W |
Shareholding
The shareholding of Mission Cure Pharma Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Mission Cure Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mission Cure Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mission Cure Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mission Cure Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICM8947R1ZH | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mission Cure Pharma Private Limited, buy the company report.
Recent activity
Mission Cure Pharma Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Kunjanbhai Shah ceased to be Director on 13 Jun 2017.
Frequently asked questions
Mission Cure Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 October 2013 (13+ years old) and is registered under CIN U24233GJ2013PTC077247.
Mission Cure Pharma has 2 current directors:
- Devangkumar Jashvantlal Shah - Director
- Udayan Jashwantlal Shah - Director
The latest financial statements of Mission Cure Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mission Cure Pharma is 24AAICM8947R1ZH, registered in Gujarat.
The CIN (Corporate Identification Number) of Mission Cure Pharma is U24233GJ2013PTC077247. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mission Cure Pharma was incorporated on 17 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Mission Cure Pharma by revenue are Roots Life Sciences (India) Private Limited, Convene Pharma Private Limited, Tradeniger Impex Private Limited, Infochem Pharma Private Limited, Glosun Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kunjanbhai Shah ceased to be Director on 13 Jun 2017. Udayan Jashwantlal Shah was appointed as Director on 09 Jun 2017. Devangkumar Jashvantlal Shah was appointed as Director on 17 Oct 2013.
The registered office of Mission Cure Pharma is at Ground Floor Shop – 9 Binali Complex Opp. Torrent Power Ltd. Sola Road Nara, Npura, Ahmedabad, Gujarat, India – 380013.
Mission Cure Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Mission Cure Pharma is compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
